Aortic Stiffness in Patients With Genetic Aortopathies
PULSEWAVE
1 other identifier
observational
250
1 country
1
Brief Summary
The goal of this observational study is to study arterial stiffness in patients with thoracic ascending aortic aneurysms (TAA), either syndromic or non-syndromic. The main questions it aims to answer are:
- Stratification of aortic risk based on arterial stiffness; Compare measurements with morphological and haemodynamic features of the ascending thoracic aorta. Participants will be asked to undergo non-invasive evaluation of blood pressure and arterial stiffness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 27, 2023
CompletedFirst Posted
Study publicly available on registry
February 6, 2023
CompletedStudy Start
First participant enrolled
February 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedSeptember 10, 2025
July 1, 2025
2.8 years
January 27, 2023
September 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pulse Wave Velocity
Statistic analysis will be performed using the Statistical Package for Social Science (SPSS for Windows; v20.0; SPSS, Chicago, Illinois, USA). Continuous variables will be expressed as mean ± Standard Deviation, while qualitative variables will be expressed as a percentage. Qualitative data will be compared using Fisher's test or Pearson's χ2 test, when appropriate. Continuous variables by t-test or analysis of variance normalized for covariates. Continuous variables will be correlated by simple or multiple linear regression
18 months
Study Arms (2)
Syndromic TAA
Subjets with clinical or genetic diagnosis of syndromic thoracic aortic aneurysms
Non-syndromic TAA
Subjets without clinical or genetic diagnosis of syndromic thoracic aortic aneurysms
Interventions
Eligibility Criteria
Patients with ascending aortic aneurysms currently in follow.up at Cardiovascular Gentic Centre, IRCCS Policlinico San Donato.
You may qualify if:
- Subjects with AAT, either syndromic or non syndromic;
- Signed informed consent
You may not qualify if:
- Patients with early menopause and/or osteoporosis, rheumatic heart disease and active malignant tumours;
- Patients with acute and chronic inflammatory conditions such as: chronic liver disease, chronic renal insufficiency and diseases affecting the thyroid system;
- Seropositivity to HIV, HCV, HBsAg and SARS-CoV-2;
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- IRCCS Policlinico S. Donatolead
- Istituto Auxologico Italianocollaborator
Study Sites (1)
IRCCS Policlinico San Donato
San Donato Milanese, Lombardy, 20097, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alessandro Pini
Cardiovascular-Gentic Centre, IRCCS Policlinico San Donato
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 27, 2023
First Posted
February 6, 2023
Study Start
February 15, 2023
Primary Completion
November 30, 2025
Study Completion
December 31, 2025
Last Updated
September 10, 2025
Record last verified: 2025-07